Currently, healthcare organizations use robot technology for thoracic, abdominal, pelvic, and neurological surgical procedures. The use of robot-assisted surgery improves quality of care because the patient experiences less pain after the surgery. Robot assisted surgery has demonstrated definite advantages for the patient, physician, and hospital; yet many healthcare organizations have not been able to obtain such technology due to implementation costs and lack of approval by the FDA.
The global market for surgical robots was valued at US$3.9 billion in 2018 and is anticipated to reach US$6.5 billion with a CAGR of 10.4%. However, as technology evolves and robotics in healthcare has reached a certain extent of innovation; emerging trends like robotic arms, micro-robots are expanding the role of robots in the sector. Even though the high cost of surgical robots is a barrier to adoption, the healthcare industry is still dedicating a part of its revenue to stay at the edge. Applications of AI to clinical data for diagnostic purposes have already begun to demonstrate capability approximating that of specialist physicians.
The next iteration of surgical robots conforms human-initiated actions to a personalized surgical plan leveraging 3D digital segmentation generated prior to surgery. Inspired by the successful application of deep learning, several surgical companies are joining hands with tech giants to develop intelligent surgical robots.
Robotic Surgery also often makes minimally invasive surgery possible. The benefits entailed by this are:
· Fewer complications, such as surgical site infection
· Less pain and blood loss
· Quicker recovery
· Smaller, less noticeable scars
To understand the advancements, and the benefits of robotic assisted surgery, and to learn from the valuable insights and discussion between a panel of experts, join Group Futurista at the webinar “Future of Robotic Assisted Surgery”.